ASEAN-NDI SBP, catalyst for collaborative innovation in health R & D
Stakeholders of the ASEAN – Network for Drugs, Diagnostics, Vaccines, and Traditional Medicine Innovation (ASEAN-NDI) convened last June 5 at the Dusit Thani Hotel, Makati City, Philippines, to discuss the network’s Strategic Business Plan (SBP), learn from the best practices/experience of other regional R&D innovation networks in China and Africa, and lay down plans for ASEAN-NDI, including the proposed activities and funding opportunities for the network.
ASEAN Economic Community (AEC) Biomedical Innovation Forum 2013
An International Conference and Exhibition on Health Technology for Development (14-16 November 2013, Bangkok, Thailand 2013)
The global biomedical industry continues to grow at impressive rates. The growth is non homogenous. Asia for example has experienced a growth rate of over 10% per year over the last decade. While powerhouse countries like China, Korea and Japan have accounted for the majority of the Asian market, domestic growth in South East Asia (ASEAN) countries are fast expanding, and should not be overlooked. In 2015, ten countries in the region will join and become a single market and population, known as the ASEAN Economic Community (AEC).
Myanmar hosts the ASEAN 63rd Meeting of the COST
NAY PYI TAW, MYANMAR- Leaders, Delegates, and Representatives from the region are now holding the Association of Southeast Asian Nations (ASEAN) 63rd Meeting of the Committee on Science and Technology (COST) at the Myanmar International Convention Center (MICC) on May 14-18, 2012.
ASEAN-NDI reviews its Strategic Business Plan
Task force members of the ASEAN Network for Drug, Diagnostics, and Vaccines Innovation (ASEAN-NDI) held a teleconference at the Asian Institute of Management (AIM) in Makati City last February 28, 2012 to review its draft Strategic Business Plan (SBP).
“The meeting was called to provide the task force members information on the progress of the SBP project. It also aims to gather reactions and post clarifications on the questionnaire provided prior to the meeting to make sure that the draft report for the project will address issues applicable to most of the countries,” explained Professor Federico Macaranas of AIM, SBP program leader and moderator of the meeting.
Task Force Members identify strategies for the network
In continuing its pursuit of establishing a network for the region, ASEAN-NDI conducted a meeting of the Task Force (TF) members held on 20 October 2011 at the Dusit Thani Hotel, Makati City, Philippines. The objective of the meeting is to discuss and agree on the framework/ initial outline of the draft ASEAN-NDI Startegic Business Plan (SBP) and the timelines for consultations/ discussions by the business development expert with the TF members. The meeting was organized to be a venue for the discussion of the SBP for ASEAN-NDI, and identification of strategies geared towards the future implementation of collaborations and partnerships within ASEAN on innovation.
ASEAN Representatives gear up for ASEAN-NDI launching
Another milestone in Research & Development (R&D) innovation was accomplished on December 6, 2010 at the Dusit Thani Manila Hotel, Makati City during the meeting of ASEAN representatives and World Health Organization (WHO) officials. The said event was organized to hold the 2nd meeting of Country Coordinators of the ASEAN product R&D mapping for infectious diseases, and consult with other ASEAN representatives regarding the plan for the proposed ASEAN Network for Drugs, Diagnostics and Vaccines Innovation (ASEAN-NDI).
Site Built By WeAreLegendary